These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4187556)

  • 1. L-dopa and juvenile Huntington's disease.
    Barbeau A
    Lancet; 1969 Nov; 2(7629):1066. PubMed ID: 4187556
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Treatment of Huntington's chorea.
    Candelise L; Faglioni P; Spinnler H; Vignolo LA
    N Engl J Med; 1973 Nov; 289(22):1201. PubMed ID: 4271092
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of L-dopa in the detection of presymptomatic Huntington's chorea.
    Klawans HL; Paulson GW; Ringel SP; Barbeau A
    N Engl J Med; 1972 Jun; 286(25):1332-4. PubMed ID: 4260358
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa in Huntington's chorea.
    Tan BK; Leijnse-Ybema HJ; v d Brand HJ
    Lancet; 1972 Apr; 1(7756):903. PubMed ID: 4111857
    [No Abstract]   [Full Text] [Related]  

  • 5. Huntington's chorea--the rigid form (Westphal variant) treated with l-DOPA: a case report.
    Low PA; Allsop JL
    Proc Aust Assoc Neurol; 1973; 10(0):45-6. PubMed ID: 4275960
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA].
    Simanyi M; Gerstenbrand F; Gründig E; Schedl R; Weiss H
    Z Neurol; 1973 Mar; 204(1):67-80. PubMed ID: 4121504
    [No Abstract]   [Full Text] [Related]  

  • 7. DOPA as anti-metabolite in Huntington's disease.
    Shokeir MH
    Lancet; 1973 May; 1(7810):1005-6. PubMed ID: 4121569
    [No Abstract]   [Full Text] [Related]  

  • 8. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of Parkinsonism--chronic treatment with L-dopa.
    Cotzias GC; Papavasiliou PS; Gellene R
    N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641
    [No Abstract]   [Full Text] [Related]  

  • 10. Huntington's chorea: the rigid form (Westphal variant) treated with levodopa.
    Low PA; Allsop JL; Halmagyi GM
    Med J Aust; 1974 Mar; 1(11):393-4. PubMed ID: 4275254
    [No Abstract]   [Full Text] [Related]  

  • 11. Rigid pseudoparkinsonian variant of Huntington's chronic chorea. A case with early onset and the effects of L-dopa treatment.
    Christodorescu D; Costiner E
    Neurol Psychiatr (Bucur); 1979; 17(2):107-11. PubMed ID: 158214
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Huntington's chorea and levodopa.
    Schenk G; Leijnse-Ybema HJ
    Lancet; 1974 Mar; 1(7853):364. PubMed ID: 4131222
    [No Abstract]   [Full Text] [Related]  

  • 13. Dimethyl aminoethanol in Huntington's chorea.
    Walker JE; Hoehn M; Sears E; Lewis J
    Lancet; 1973 Jun; 1(7818):1512-3. PubMed ID: 4123177
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa and Huntington's chorea.
    Loeb C; Roccatagliata G; La Medica G; Abbruzzese G; Albano C
    J Neurol Neurosurg Psychiatry; 1976 Oct; 39(10):958-61. PubMed ID: 137301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-dopa effect in Huntington's chorea.
    Fahn S
    N Engl J Med; 1972 Aug; 287(9):467-8. PubMed ID: 4261530
    [No Abstract]   [Full Text] [Related]  

  • 16. Early onset rigid Huntington's disease.
    Bird MT; Paulson GW
    Neurology; 1970 Apr; 20(4):400. PubMed ID: 4254549
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopa and Huntington's disease.
    Venters GA
    Lancet; 1973 Mar; 1(7805):718. PubMed ID: 4120507
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
    Podolsky S; Leopold NA
    J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011
    [No Abstract]   [Full Text] [Related]  

  • 19. Biogenic amines in the hypothalamus: effect of L-DOPA on human growth hormone levels in patients with Huntington's chorea.
    Podolsky S; Leopold NA
    Prog Brain Res; 1973; 39():225-35. PubMed ID: 4275115
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.